Oncolytics Biotech (ONCY) - 2022 Q3 - Quarterly Report

Condensed Interim Consolidated Financial Statements (unaudited) Oncolytics Biotech Inc. September 30, 2022 and 2021 ® ONCOLYTICS BIOTECH INC. CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | | | September 30, | | December 31, | | --- | --- | --- | --- | --- | | As at | | 2022 | | 2021 | | Assets | | | | | | Current assets | | | | | | Cash and cash equivalents (note 4) | $| 32,362,063 |$ | 41,262,044 | | Other receivables (note 8) | | 496,855 | | 866,055 | | Prepaid expenses | | 5,346,353 ...